1. Luo, Xingguang, Kranzler, Henry R, Zuo, Lingjun, Blumberg, Hilary P, Gelernter, Joel. 2005. CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case-control structured association study. In Human molecular genetics, 14, 2421-34. doi:. https://pubmed.ncbi.nlm.nih.gov/16000316/
2. Zhang, Lin, Hu, Aihua, Yuan, Haixin, Zhao, Rongrui, Shen, Yan. 2008. A missense mutation in the CHRM2 gene is associated with familial dilated cardiomyopathy. In Circulation research, 102, 1426-32. doi:10.1161/CIRCRESAHA.107.167783. https://pubmed.ncbi.nlm.nih.gov/18451336/
3. Dick, Danielle M, Aliev, Fazil, Kramer, John, Goate, Alison, Bierut, Laura. 2006. Association of CHRM2 with IQ: converging evidence for a gene influencing intelligence. In Behavior genetics, 37, 265-72. doi:. https://pubmed.ncbi.nlm.nih.gov/17160701/
4. Ding, Ming, Arnold, Jennifer, Turner, Jeremy, Trammell, Rita A, Toth, Linda A. . Lack of association of a spontaneous mutation of the Chrm2 gene with behavioral and physiologic phenotypic differences in inbred mice. In Comparative medicine, 60, 272-81. doi:. https://pubmed.ncbi.nlm.nih.gov/20819376/
5. Mobascher, A, Rujescu, D, Mittelstraß, K, Dahmen, N, Winterer, G. . Association of a variant in the muscarinic acetylcholine receptor 2 gene (CHRM2) with nicotine addiction. In American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, 153B, 684-690. doi:10.1002/ajmg.b.31011. https://pubmed.ncbi.nlm.nih.gov/19644963/
6. Zink, Nicolas, Bensmann, Wiebke, Arning, Larissa, Stock, Ann-Kathrin, Beste, Christian. 2019. CHRM2 Genotype Affects Inhibitory Control Mechanisms During Cognitive Flexibility. In Molecular neurobiology, 56, 6134-6141. doi:10.1007/s12035-019-1521-6. https://pubmed.ncbi.nlm.nih.gov/30729426/
7. Sakata, Kazuko, Overacre, Abigail E. 2017. Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments. In Journal of neurochemistry, 143, 49-64. doi:10.1111/jnc.14129. https://pubmed.ncbi.nlm.nih.gov/28722769/
8. Zhang, Jixiang, Chen, Shao-Rui, Chen, Hong, Pan, Hui-Lin. 2018. RE1-silencing transcription factor controls the acute-to-chronic neuropathic pain transition and Chrm2 receptor gene expression in primary sensory neurons. In The Journal of biological chemistry, 293, 19078-19091. doi:10.1074/jbc.RA118.005846. https://pubmed.ncbi.nlm.nih.gov/30327427/